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Abstract
Diamond nanoparticles (nanodiamonds) have been recently proposed as new labels for cellular
imaging. For small nanodiamonds (size < 40 nm) resonant laser scattering and Raman scat-
tering cross-sections are too small to allow single nanoparticle observation. Nanodiamonds can
however be rendered photoluminescent with a perfect photostability at room temperature. Such
a remarkable property allows easier single-particle tracking over long time-scales. In this work
we use photoluminescent nanodiamonds of size < 50 nm for intracellular labeling and investigate
the mechanism of their uptake by living cells . By blocking selectively different uptake processes
we show that nanodiamonds enter cells mainly by endocytosis and converging data indicate that
it is clathrin mediated. We also examine nanodiamonds intracellular localization in endocytic
vesicles using immunofluorescence and transmission electron microscopy. We find a high degree
of colocalization between vesicles and the biggest nanoparticles or aggregates, while the smallest
particles appear free in the cytosol. Our results pave the way for the use of photoluminescent
nanodiamonds in targeted intracellular labeling or biomolecule delivery.
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1 Introduction
Solid-state nanoparticles hold great promises for biomedical applications, notably thanks to the
possibility to combine biological and inorganic materials with the prospect to develop innovative
diagnostic and therapeutic tools. Among them, nanoparticles like quantum dots (1, 2), gold
nanobeads (3) or silicon beads (4) are used to label biomolecule with high specificity, to track
their fate in cultured cells and in organisms or even to deliver bioactive molecules or drugs.
Organic dyes and fluorophores are nowadays the most widely used biomolecules fluorescent labels.
However they photobleach rapidly under continuous illumination (5), which makes difficult their
quantification and long term follow-up. Interestingly, semiconductor nanocrystals, or quantum
dots (QDs), have a better stability and a lower photobleaching yield than organic dyes. They
also offer the possibility of multicolor staining by size tuning (2). On the other hand, such
nanoparticles present major drawbacks, such as a potential cytotoxicity on long-term scale due
to the chemical composition of their core (6) or the intermittency of their photoluminescence
(photoblinking) which makes difficult an efficient tracking of individual nanoparticles (7).
Compared to these nanoparticles, photoluminescent nanodiamonds (PNDs) appear as promising
alternative biomarkers. Their photoluminescence, with emission in the red and near infrared
spectral region (575-750 nm) results from nitrogen-vacancy (NV) color centers embedded in the
diamond matrix (8). These emitters present a perfect photostability with no photobleaching nor
photoblinking, and a photoluminescence intensity which is only three times smaller than that of
a single commercial QD, a situation which can be reversed in favor of NDs by the use of particles
containing a large number of color centers (9). Such remarkable photoluminescent properties
have made possible long-term single particle tracking in living cells (9, 10, 11).
Moreover, thanks to a large specific surface area, the nanodiamond can be used as a platform to
graft a large variety of bioactive moieties (12, 13, 14, 15) with the perspective to use these particles
for instance as intracellular compartment labels (16) or as long term traceable delivery vehicles for
biomolecule translocation in cell (14, 15, 17, 18). Considering the recent demonstrations of PNDs
mass production (11, 19), and the numerous experiments showing their low cytotoxicity (17, 20,
21, 22), one can envision large scale applications of these biolabels. However, such outstanding
prospects require a better understanding of the mechanism underlying their cellular uptake.
To that end, we study in the present work the cellular fate of photoluminescent nanodiamonds of
size <50 nm. We first show that for such a small size nanodiamonds, excitation-laser scattering
yields no signal and that only photoluminescence allows their detection with a sufficient signal-
to-background ratio. We then carry out a systematic investigation of the cellular uptake and
pathway of PNDs in human cancer cells (HeLa cells) and observe that the internalization of
PNDs stems mainly from endocytosis.
The localization of PNDs in cells is studied using simultaneous detection of PNDs and immunoflu-
orescence methods to label the endosomes and the lysosomes.
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2 Results and discussion
2.1 Nanodiamond observation at the single particle level in cells
In the present work, we use nanodiamonds produced by milling of 150-200 µm diamond micro-
crystals after the activation of their photoluminescence by the creation of NV color centers in the
diamond matrix (see Materials and Methods). We then selected from an aqueous suspension of
the milled product, using differential centrifugations, a subset of nanodiamonds having a mean
hydrodynamic diameter centered on 46 nm. Since diamond refractive index (2.4) is about twice
larger than that of the cellular medium, diamond can yield a higher back-scattered intensity of
the excitation laser light than the cell compartments. Such a scattering signal can then be used
to image nanodiamonds in cell with a good contrast (10, 23). However, the scattering intensity
decreases rapidly with particle size, due to its sixth order dependence on the particle diameter
(Rayleigh scattering). It was shown that the smallest nanodiamonds detectable by this technique
have sizes of 37 nm (24).
Accordingly, we observe that NDs size is too small to image the particles in cell by back-scattered
light with a reasonable signal-to-background ratio that can compete with the photoluminescence
signal. Figure 1 shows a HeLa cell imaged with a standard confocal microscope (Leica TCS SP2)
in three different contrast modes: (a) backscattering (sometimes referred as the “reflection”
mode) of the incident laser operating in cw regime at an excitation wavelength of 488 nm,
(b) photoluminescence excited by the same laser and detected in the NV color center spectral
region and (d) DIC (Differential Interference Contrast) obtained in transmission under white
light illumination of the sample. Two PNDs are detected by all the contrast modes and probably
correspond to particles bigger than 50 nm (orange arrows pointing to the right on Figure 1c). On
the contrary, a few PNDs are only detected in the fluorescence mode (three of them are marked
with yellow arrows pointing to the left on Figure 1c). Complementary observations done with a
home-made confocal microscope having single color-center sensitivity confirm this result. These
experiments indicate that fluorescence microscopy is the most appropriate method to detect the
smallest PNDs internalized by cells. Moreover, a higher PNDs photoluminescence intensity can
be achieved by increasing the number of color centers created per particle. A recent report on
PNDs produced a technique similar to the one used here shows that, by optimizing the NV
color center creation, one can reach a concentration up to 12 NV centers in nanodiamonds of
size around 10 nm (19). Such a result is very promising for the tracking of very small PNDs in
cell.
2.2 Mechanism of PNDs uptake by cells
It is well established that NDs can spontaneously enter cultured cells, as demonstrated by confocal
microscopy (14, 20, 21). In this work we further investigated the internalization mechanism of
PNDs in HeLa cells.
We quantified the dynamics of the PNDs uptake by cells by monitoring the overall cell fluo-
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Figure 1: Imaging of photoluminescent nanodiamonds internalized in HeLa cells in three different
contrast modes of a Leica TCS SP2 microscope: (a) raster-scan of back-scattered excitation laser
light (wavelength 488 nm). (b) photoluminescence confocal raster-scan in the NV color center
emission spectrum region (red channel, refer to Materials and Methods). (c) overlay of (a)
and (b): orange arrows, pointing to the right, exhibit nanoparticles that are observed in both
backscattered and fluorescence modes, while the yellow arrows pointing to the left show some
nanodiamonds that are detected only in the photoluminescence mode; (d) DIC image obtained
in transmission with white light illumination. The confocal section (b) was acquired with laser
focusing into the plane located 2.5 µm above the coverglass surface on which the cell was grown.
rescence intensity (refer to Materials and methods) and we found that the uptake follows an
exponential behavior with time, with a characteristic uptake half-life of 2.6 h. These measure-
ments are in agreement with the 3 h uptake half-life observed for 70 nm PNDs (25) and the 1.9 h
reported for 50 nm gold nanoparticles (26).
Endocytosis is considered as the dominant uptake mechanism of extracellular materials of size
up to about 150 nm (27, 28). We therefore evaluated the contribution of endocytosis to NDs
internalization by HeLa cells. For this purpose, the cells were incubated with PNDs (concen-
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tration 20 µg/ml) under different conditions: (i) at 37◦C (control), (ii) at 4◦C and (iii) after
pretreatment with NaN3. The latter treatment disturbs the production of ATP and blocks the
endocytosis (29) which is an energy-dependant process. Incubation of the cells at 4◦C is also
known to block endocytosis.
Figure 2: Nanodiamonds are uptaken by HeLa cells through endocytosis. Merged photolumi-
nescence confocal raster scans (red channel) and DIC images of PNDs (concentration 20 µg/ml)
incubated for 2 hours with cells (a) at 37◦C (control) and (b) at 4◦C, or at 37◦C but after
pretreatment with either (c) NaN3 (10 mM), or (d) sucrose (0.45 M), or (e) filipin (5 µg/ml).
Confocal scans are acquired at z = 1.5 µm above the coverglass surface, laser excitation power:
0.5 mW. (f) Mean photoluminescence intensity per cell (in the red channel) for the different cell
treatments, normalized to the one of control cells and evaluated as described in Materials and
Methods.
For the analysis of NDs uptake under different cellular treatments, we used the Leica TCS SP2
confocal microscope. Figure 2 shows that when endocytosis is hindered by low temperature or
NaN3, the photoluminescence signal from PNDs strongly decreases (Figure 2b,c) compared to the
control (Figure 2a). Similar results were obtained using the home-built confocal microscope which
is able to detect all PNDs, including those containing only a single color center, presumably the
smallest nanoparticles. These observations, together with the fact that the majority of the NDs
from the sample exhibit some photoluminescence (Figure 5, Materials and methods), strongly
suggest that very few NDs are internalized when endocytosis is blocked.
To further documant the endocytosis mechanisms involved in the cellular uptake of nanodia-
monds, we investigated the receptor-mediated endocytosis (RME) pathway. In RME a ligand
4
first binds to a cell surface receptor and is then internalized through an invagination of the plasma
membrane. Among the different RME processes, the clathrin mediated pathway is the most fre-
quent one. Clathrin is a protein which coats cell membrane invaginations leading to the budding
of clathrin-coated vesicles (30, 31). Other main RME processes, which are clathrin-independent,
occur through the caveolae pathway. Caveaolae are invaginations rich in cholesterol (32). In our
experiments, cells were incubated with PNDs under conditions that inhibit either the clathrin
or the caveolae pathways. Interestingly, we observe that pretreatment of cells with sucrose, a
hypertonic treatment known to disrupt the formation of clathrin-coated vesicles (33, 34), reduces
to a high degree the PNDs uptake (Figure 2d). To block the caveolae pathway, cells were pre-
treated with filipin which disrupts the formation of the cholesterol domains (34, 35). In contrast
to the clathrin-pathway blocking experiment, we observe that pretreatment with filipin does not
hinder the internalization of PNDs (Figure 2e). These results indicate that PNDs are mainly
internalized by cells by the clathrin-mediated pathway.
For a more quantitative analysis, we evaluated the mean photoluminescence intensity per cell (in
the red channel, corresponding to NV color center emission), in a way similar to the one used
for the dynamic measurement of PNDs cellular internalization. Figure 2f shows the change of
the mean photoluminescence intensity per cell, normalized to that of control cells. This graph
summarizes quantitatively the effects of the different cell treatments, and supports the conclusion
that the uptake mechanism of PNDs is endocytosis, with strong indications that it is clathrin
mediated. The latter statement is reinforced by a complementary analysis done on nanodiamond
surface functions. We studied by FTIR spectroscopy the modifications of ND surface functions
signatures before and after their mixture with serum supplemented culture medium. We observed
that proteins of the serum are adsorbed onto the nanodiamond surface, which may facilitate a
receptor-mediated endocytosis. Concomitantly, we noticed that the addition of serum greatly
improves the stability of the nanodiamond suspension in the culture medium, which is also related
to surface modifications impacting its electric charge.
The present results on nanodiamond internalization pathway are close to those obtained on
the same HeLa cell line for other types of nanoparticles with similar sizes, like gold nanopar-
ticles (26) or single-walled carbon nanotubes noncovalently conjugated with DNA molecules or
proteins (36).
2.3 Intracellular localization of PNDs
After an endocytic uptake, the internalized compound is expected to be found in intracellular
endosomal and lysosomal vesicles, before eventually being released in the cytosol or expelled
from the cell. Endosomes are vesicles involved in the transport of extracellular materials in the
cell cytoplasm. After internalization, endosomes are either recycled to the plasma membrane
and the receptors can be used for a novel cycle or they are fused with lysosomes (30).
In a previous study we concluded from immunofluorescence analyses that 25 nm PNDs are
partially colocalized with early endosomes (21). Here we provide similar but more complete
results obtained with PNDs differently produced. Apart from a difference in the mean size
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between the two kinds of PNDs, the nanoparticles have not the same morphologies as it can be
seen on TEM images (see Figure 5c in the Materials and Methods and also Ref.(19)): the shape
of the 46 nm nanoparticles produced by milling is more spherical, while the 25 nm commercial
NDs present sharper edges (37). These differences may impact the uptake efficiency and justify
a new localization study.
Figure 3: Localization of 46 nm photoluminescent nanodiamonds in HeLa cells. Confocal fluo-
rescence raster-scan (Leica TCS SP2 microscope) of HeLa cell incubated with PNDs (10 µg/ml)
in normal (control) conditions, then fixed and labeled with endosomes or lysosomes dyes. From
left to right: raster-scan in the green channel (500-530 nm) showing the endocytic compart-
ments; in the red channel (600-750 nm) showing the PNDs. Images on the right represent the
merged the green and red scans. (a) Colocalization study of PNDs with early endosomes labeled
with EEA1-FITC fluorescent conjugate. (b) Colocalization of PNDs with lysosomes labeled with
LysoTracker Green dye. PNDs colocalized with endosomes or lysosomes appear in yellow in the
merged fluorescence scans.
Early endosomes and lysosomes were marked with fluorescent labels emitting in the green spec-
tral region (500-550 nm), with no overlap with the red and near infrared emission of NV color
centers (Figure 5d). Scanning confocal imaging was carried out with the Leica TCS SP2 mi-
croscope. The red channel detection spectral range selected for PNDs imaging is 600-750 nm
to avoid again any overlap with the emission of the cellular components labels. Figure 3 shows
a high degree of colocalization of PNDs with both early endosomes and lysosomes, which sup-
ports the fact that NDs follow the course of the endocytic cycle. This endosomal localization of
PNDs again agrees with reports on other kind of similar size nanoparticles, like QDs (38) or gold
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nanobeads (26, 39).
To further elucidate the fate of the smallest and less bright PNDs that cannot be detected with the
Leica TCS SP2 microscope, we examined the same samples with two complementary techniques:
with the home-built confocal setup detecting the smallest photoluminescent PNDs and with
electron microscopy. Observations with the home-built confocal microscope show a partial colo-
calization, which is also confirmed by Transmission Electron Microscopy (TEM) imaging. In the
latter technique, NDs particles appear as dark spots on the grey cytoplasmic background 1.
In the large scale TEM image (Figure 4a) of a part of a HeLa cell incubated with PNDs, one can
observe the nanoparticles in the cytoplasm. They are either trapped in vesicles (Figure 4b,f),
or free in the cytosol (Figure 4d). NDs trapped in vesicles form aggregates (Figure 4b), and
represent the majority of the nanodiamonds observed by TEM inside the cell cytoplasm. This
is in agreement with our colocalization studies and with the confined motion of PNDs observed
with wide-field microscopy (11, 21). Nanodiamonds which are free in the cytosol correspond to
the smallest particles that can be observed at their primary size (¡5-10 nm) or as small aggregates
of a few particles. These free nanoparticles have either been released from the endosomes or may
have been directly internalized via passive transport (like facilitated diffusion) through the cell
membrane. Interestingly, all internalized nanodiamonds, even of the smallest size (¡5 nm) are
observed in perinuclear regions and none of them seems to be present inside the nucleus.
3 Conclusion
In this work we used 46 nm mean size photoluminescent diamond nanoparticles produced by
micron-size diamond milling as cell labels. We showed that photoluminescence detection allows
imaging the smallest nanodiamonds that cannot be observed by the backscattered light of the
excitation laser. This result underlines the superiority of photoluminescence for tiny nanodia-
monds imaging in complex environments such as the intracellular medium. With the use of a
commercial laser scanning confocal microscope, we showed that the internalization of PNDs in
HeLa cells occurs through endocytosis and we have strong indications that it is receptor-mediated
via the clathrin pathway. We observed that most of the nanodiamonds are localized in intracel-
lular endocytic vesicles in the perinuclear region, except for a small portion, in particular the
smallest particles, that appear to be free in the cytoplasm. As cell is an inhomogeneous medium,
a careful understanding of the distribution of nanoparticles into the cytoplasm and the reasons
of the variability of their fate represents a critical step towards the use of diamond nanoparticles
for targetted biomolecule delivery, with a long-term intracellular tracking possibility through its
photoluminescence.
1We examined by carrying out a local area Fourier transform electron diffractogram on one of the TEM dark
spots of size ≃10 nm that it has the signature of diamond material (inset of Figure 4e).
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Figure 4: Transmission Electron Microscopy images of a HeLa cell incubated with PNDs for
2 hours. (a) Large scale image. (b) NDs trapped in intracellular vesicles, N indicates the position
of cell nucleus. (c) NDs outside the cell and on the cell membrane (blue arrows), probably during
the early stage of the internalization process, since the half-life uptake (2.6 hours) is longer than
the incubation time. (d) free NDs in the cytoplasm. (e) zoom on one 10 nm ND, inset : local
area Fourier transform diffractogram of this ND. (f) PNDs trapped in an intracellular vesicle of
another cell from the same sample.
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4 Materials and Methods
4.1 Production and characterization of Photoluminescent NanoDia-
monds (PNDs)
The PNDs production is described in details in Ref. (19). Briefly, the starting material was type
Ib diamond synthetic micron size powder (Element Six, The Netherlands) with a specified size of
150-200 µm. NV centers were created by electron irradiation (irradiation dose 2× 1018 e−/cm2,
beam energy 8 MeV) and subsequent annealing (800◦C, 2 h) in vacuum (pressure ≃ 10−8 mbar)
. Diamond microcrystals were then reduced in size by nitrogen jet milling to obtain submicron
size crystals (Hosokawa-Alpine, Germany). Further size reduction to nanoparticles was achieved
by ball milling under argon (Fritsch, Germany). The milled powder was then sieved and treated
by strong sonication (60 min at 50◦C), followed by acid treatment. After rinsing with pure water,
filtration and centrifugation, we obtained PNDs with an average hydrodynamic diameter of 46 nm
in a stable water suspension. The size measurement was done by dynamic light Scattering (DLS)
corrected from Mie scattering, using the DL135 particle size analyzer (Cordouan Technologies,
France). The associated zeta potential of this solution was -43 mV (Zetasizer Nano ZS from
Malvern, UK).
To simultaneously characterize the PNDs in size and photoluminescence intensity, we used an
Atomic Force Microscope (AFM, MFP-3D Asylum Research) coupled to a home-built confocal
microscope setup. For such a study, a droplet of the PND aqueous suspension was deposited
by spin-coating on a glass coverslip which was then simultaneously imaged in AFM (Figure 5a)
and photoluminescence (Figure 5b) modes. Among 200 nanodiamonds identified on the AFM
scan, 115 display a photoluminescence signal, i.e. about 58% of the NDs are photoluminescent.
Among the photoluminescent nanoparticles a small fraction consists of 10-15 nm diameter PNDs,
but the majority of the PNDs appears as nano-objects of size 40-50 nm. Some of them form
aggregates of 2-3 smaller particles, as can be inferred from TEM imaging (Figure 5c).
4.2 Photoluminescence and backscatterred light imaging of nanodi-
amonds
The large scale photoluminescence observations of PNDs in the cells which are presented in the
main text are done with a commercial Leica TCS SP2 (Manheim, Germany) laser scanning con-
focal microscope, with a ×63, 1.4 numerical aperture (NA) oil-immersion objective. Excitation
comes from the cw argon ion laser line at 488 nm wavelength. We use one Airy Unit as the pinhole
diameter, for all the acquisitions. The detection was done in two non-overlapping spectral chan-
nels: green channel (500-530 nm) collecting the fluorescence from FITC and LysoTracker-green
dye conjugates, and the red channel (600-750 nm) collecting mainly NV− photoluminescence (see
Figure 5d).
For the single particle analysis presented in the Supporting Information, the photoluminescence
was probed using a home-built scanning-stage confocal microscope. It relies on a Nikon TE300
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Figure 5: Simultaneous size and photoluminescence characterization of the PNDs used in this
work. Sample is a coverglass on which an aqueous suspension of PNDs is deposited by spin-
coating. (a) and (b): raster scans (18 × 18 µm) of the same region of the sample in the two
modes (a) AFM and (b) confocal microscopy. For confocal imaging, the excitation laser wave-
length is 532 nm, at an excitation power of 200 µW, and the photoluminescence intensity scale
bar maximum of graph (b) was set to 90 counts/10 ms in order to be able to observe the less in-
tense PNDs (the brightest spot yields 367 counts/10 ms). Two nanodiamonds of height ∼40 nm
are circled in yellow, while a 12 nm height nanodiamond is inside the green circle, still displaying
a strong photoluminescence signal. (c) High-Resolution TEM image of the same type of PNDs.
A droplet of the aqueous suspension was initially dried on the carbon grid. (d) Photolumines-
cence spectrum of NV color centers embedded in the starting micron-size diamond crystal (after
irradiation and before milling). The narrow lines pointed out by arrows at 575 nm and 637 nm
indicate respectively the zero-phonon lines of the neutral NV◦ and negatively charged NV− color
centers, present in this sample. The light red/green rectangles behind NV spectra indicates
the spectral range selected by the red/green channels filters respectively on the Leica TCS SP2
microscope for PNDs .
microscope, converted to a confocal setup with the appropriate modifications. The microscope
objective used is a ×60, 1.4 numerical aperture (NA) apochromatic oil immersion objective.
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The excitation is a cw laser emitting at the wavelength of 488 nm. The photoluminescence
signal was acquired by an avalanche photodiode in the single-photon counting mode. This
home-built confocal setup is sensitive to the photoluminescence of a single NV color center
in a PND, in a cultured cell environment (21). To record the backscattered excitation laser
light, we used a properly oriented quarter-wave plate and polarizing beam-splitter cube assembly
to redirect all the reflected light towards an other avalanche photodiode in the single-photon
counting mode.
For the PNDs uptake kinetics study, we estimated from the confocal raster scans the mean
fluorescence intensity per cell in the red channel. For this purpose we used the mean intensity
analysis/measure tool of ImageJ software (NIH, USA). About 40 cells were analyzed for each
different incubation time.
4.3 Cell culture conditions and test of nanodiamond cytotoxicity
HeLa cells were grown in standard conditions on glass coverslips in Dulbecco modified Eagle
medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 1% penicillin/streptomycin.
To study the cellular uptake of PNDs, cells were seeded at a density of 2 × 105 cells/1.3 cm2
and grown at 37◦C in a humidified incubator under 5% CO2 atmosphere. 24 h after seeding, the
PNDs aqueous suspension was added to the cell culture medium. The cells were grown under
similar conditions for an additional period of time (from 2 h for fluorescence examination, up to
24 h for the cytotoxicity tests). After incubation, the excess of PNDs was removed by washing
the cells with phosphate buffer saline (PBS). The cells were then fixed with 4% paraformaldehyde
in PBS and mounted on microscope slides for phase contrast and confocal microscopy studies. A
necessary requirement to use PNDs as biomolecule markers is their low cytotoxicity. As cytotox-
icity depends on the cellular type used and the size, shape and charge of the nanoparticles (40),
we performed cytotoxicity tests for the PNDs used here. We show that they are not toxic in
vitro after 24 h of incubation with cells (data not shown).
4.4 Cellular uptake of nanodiamonds
To investigate the uptake mechanism of PNDs, cells were treated as follows:
Experiments blocking the endocytosis (energy dependent process): for low temperature incubation,
cells were grown as described above with the cell culture kept at 4◦C instead of 37◦C. For
the incubation with PNDs under ATP depletion, the cells were preincubated in PBS buffer,
supplemented with 10 mM NaN3 during 30 min at 37
◦C and then PNDs were added.
For the investigation of the type of receptor-mediated endocytosis mechanism, cells
were treated as follows:
Hypertonic treatment to hinder the clathrin-mediated process : the cells were pre-incubated for
30 min in PBS buffer supplemented with 0.45 M sucrose followed by incubation with PNDs at
37◦C.
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Filipin treatment blocking caveolae pathway : the cells were pretreated in PBS buffer, supple-
mented with filipin (5 µg/ml) for 30 min before exposure to PNDs at 37◦C.
For PNDs intracellular localization analyses by immunofluorescence, the endosomes were
labeled with FITC-conjugated Mouse Anti-human Early Endosome Antigen EEA1 (Ref. 612006,
BD Transduction Laboratories, USA) (21). FITC dye has absorption/emission maxima at
490/520 nm respectively. The lysosomes were labeled with LysoTracker Green DND-26 dye
(L7526, Invitrogen, USA), with absorption/emission maxima at 504/511 nm respectively. Af-
ter two hours of incubation of PNDs at 37◦C with the cells, the medium was replaced with
prewarmed new medium containing the LysoTracker probe (75 nM), for one additional hour
of incubation. The medium was then replaced with fresh medium just before cell fixation as
described above.
4.5 Transmission electron microscopy
The electron microscopy observations were done with a High Resolution Transmission Electron
Microscope (HR-TEM, Tecnai F20 operating at 200 keV). Cells were seeded for 24 h in standard
conditions (conditions similar to those used for fluorescence experiments). PNDs were added
in cell culture medium and incubated for 2 h at 37◦C. Cells were then fixed in a solution of
paraformaldehyde, glutaraldehyde and phosphate buffer for 45 min at room temperature. After
dehydration with a graded series of ethanol, the cells were embedded in EPON resin. Ultrathin
sections of the resin block were then cut (100 nm thickness) and stained with 2% uranyl acetate,
for a higher contrast imaging under the HR-TEM microscope.
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